Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oxytocin nasal spray in fibromyalgic patients: additional information : reply to the comment to the editor entitled "future directions for the investigation of intranasal oxytocin and pain".

Literature DB >> 25070143

Oxytocin nasal spray in fibromyalgic patients: additional information : reply to the comment to the editor entitled "future directions for the investigation of intranasal oxytocin and pain".

Roberta Agabio¹, Sergio Mameli, Salvatore Sardo, Luigi Minerba, Maria Rosaria Melis.

Abstract

Entities: Disease Species

Mesh：

Substances：
Oxytocin

Year: 2014 PMID： 25070143 DOI： 10.1007/s00296-014-3101-4

Source DB: PubMed Journal: Rheumatol Int ISSN： 0172-8172 Impact factor: 2.631

× No keyword cloud information.

15 in total

1. [Decreased pain sensitivity in man after treatment with superlow doses of oxytocin].

Authors: Iu V Uryvaev; G A Petrov
Journal: Biull Eksp Biol Med Date: 1996-11

2. Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome.

Authors: D Louvel; M Delvaux; A Felez; J Fioramonti; L Bueno; Y Lazorthes; J Frexinos
Journal: Gut Date: 1996-11 Impact factor: 23.059

3. Future directions for the investigation of intranasal oxytocin and pain: Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. E-pub ahead of print. doi: 10.1007/s00296-014-2953-y).

Authors: Joshua A Rash; Tavis S Campbell
Journal: Rheumatol Int Date: 2014-06-18 Impact factor: 2.631

4. Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial.

Authors: B Ohlsson; M Truedsson; M Bengtsson; R Torstenson; K Sjölund; E S Björnsson; M Simrèn
Journal: Neurogastroenterol Motil Date: 2005-10 Impact factor: 3.598

Review 5. Oxytocin and pain: a systematic review and synthesis of findings.

Authors: Joshua A Rash; Aldo Aguirre-Camacho; Tavis S Campbell
Journal: Clin J Pain Date: 2014-05 Impact factor: 3.442

6. Salivary levels of oxytocin remain elevated for more than two hours after intranasal oxytocin administration.

Authors: Renske Huffmeijer; Lenneke R A Alink; Mattie Tops; Karen M Grewen; Kathleen C Light; Marian J Bakermans-Kranenburg; Marinus H van Ijzendoorn
Journal: Neuro Endocrinol Lett Date: 2012 Impact factor: 0.765

7. The effect of intranasal oxytocin administration on acute cold pressor pain: a placebo-controlled, double-blind, within-participants crossover investigation.

Authors: Joshua A Rash; Tavis S Campbell
Journal: Psychosom Med Date: 2014 Jul-Aug Impact factor: 4.312

2. Intranasal oxytocin and NSAIDs : Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. 2014 Aug;34(8):1047-52.).

Authors: Kenneth K Kwong; Suk-tak Chan
Journal: Rheumatol Int Date: 2014-10-30 Impact factor: 2.631

2 in total

Oxytocin nasal spray in fibromyalgic patients: additional information : reply to the comment to the editor entitled "future directions for the investigation of intranasal oxytocin and pain".

1. [Decreased pain sensitivity in man after treatment with superlow doses of oxytocin].

2. Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome.

3. Future directions for the investigation of intranasal oxytocin and pain: Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. E-pub ahead of print. doi: 10.1007/s00296-014-2953-y).

4. Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial.

Review 5. Oxytocin and pain: a systematic review and synthesis of findings.

6. Salivary levels of oxytocin remain elevated for more than two hours after intranasal oxytocin administration.

7. The effect of intranasal oxytocin administration on acute cold pressor pain: a placebo-controlled, double-blind, within-participants crossover investigation.

8. Elevated Salivary Levels of Oxytocin Persist More than 7 h after Intranasal Administration.

9. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans.

10. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models.

1. The lack of efficacy of oxytocin and NSAIDs.

2. Intranasal oxytocin and NSAIDs : Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. 2014 Aug;34(8):1047-52.).